COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead More About CSL Behring's Efforts with COVID-19
CSL Behring's New R&D Campus in Germany
Video: “Topping-out” milestone celebrated in Marburg for facility scheduled to open in 2022.
Watch Online: A Hemophilia B Documentary
The “Medical Stories” episode aired on PBS stations in 2020 and ranks as our most popular content about hemophilia B.
Finding Empowerment in R&D
Two of our leaders in research talked to Biospace about the culture at work. “It’s easy to be brave at CSL. There is that sup…
A Very Special Patient
A CSL Plasma employee in Alabama knows what it’s like to be on the other side. When her son was a baby, he needed plasma-base…
Next Stop, College
Patients offer advice for graduating high school students about managing a health condition in a university environment.
Mindfulness in Action
It can be tough to adjust to life with a serious health problem or a rare disease. Dr. Sarah Gulick helps patients enjoy life…
Leaders Who Inspire
The Healthcare Businesswomen's Association names two employees as Luminary and Rising Star honorees.
Be a Mama Bear and Other Advice for Moms
Patient advocates wish a Happy Mother’s Day to the rare disease community.